Nanotechnology Now





Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Kodak Launches New Imaging Agent Product Line for Research Applications

Abstract:
Enables Early Disease Detection and Treatment

Kodak Launches New Imaging Agent Product Line for Research Applications

New Haven, CT | Posted on February 28th, 2007

Eastman Kodak Company's Molecular Imaging Systems group announced the introduction of KODAK X-SIGHT Imaging Agents, a novel line of imaging agents for in vivo molecular imaging applications. The new product line will be shown at the 14th International Molecular Medicine Tri-Conference, beginning today in San Francisco, Calif., and running through March 2.

In vivo molecular imaging allows non-invasive measurement of biological processes within a living organism. In contrast to conventional diagnostic imaging that highlights conditions caused by disease, molecular imaging identifies molecular abnormalities that are the origin of disease at a very early stage, which can expedite the development of treatment options that could help cure that disease.

Once attached to a molecule and injected into an organism, the KODAK X-Sight imaging agents will travel to the target (such as a tumor) and highlight the region of interest. X-Sight imaging agents are non-toxic, making them safe for research studies in areas such as oncology, cardiology, diabetes, and inflammation, to name a few. They are uniquely designed to offer significant advantages over currently available agents, enabling researchers to perform pioneering research studies that could lead to a better understanding of the origin of these diseases.

This new product line leverages Kodak's 50 years of dye chemistry and nanotechnology expertise, to produce state-of-the-art nanoparticle products. X-Sight imaging agents deliver superior brightness and enhanced stability, providing researchers a versatile platform for molecular imaging. KODAK X-Sight imaging agents are available in several distinct varieties and can be adapted to a wide range of applications.

"The launch of X-Sight Imaging Agents, is a significant milestone toward offering our customers a complete solution of systems and agents to advance their research," commented Shahram Hejazi, PhD, Worldwide General Manager of Kodak's Molecular Imaging Systems division. "This introduction strengthens our leadership in the molecular imaging arena as we move forward to bridge the gap between preclinical and clinical applications."

Together with Kodak's In-Vivo Imaging Systems, the X-Sight Imaging Agent product line further expands the breadth of leading edge solutions offered from Kodak to the medical research community to accelerate life science and drug discovery research. X-Sight imaging agents are currently available for preclinical use in the United States and will be launched worldwide in March. Kodak plans to introduce additional imaging agents throughout the year.

####

About Kodak’s Molecular Imaging Systems Group
Eastman Kodak Company’s Molecular Imaging Systems group--part of Kodak’s Health Group--develops and markets high performance digital imaging systems, imaging agents, film and accessories for the life science research and drug discovery/development market segments.

For more information, visit http://www.kodak.com/go/molecular or call 1-877-747-4357, express code 7. Outside of the United States, call 203-786-5657.

Kodak and X-Sight are trademarks of Eastman Kodak Company.

For more information, please click here

Contacts:
Eastman Kodak Company
Alice Huang, 408-464-1151

Copyright © Business Wire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

New Biosensor Produced in Iran to Detect Effective Drugs in Cancer Treatment July 4th, 2015

Groundbreaking research to help control liquids at micro and nano scales July 3rd, 2015

Iranian Scientists Find Simple, Economic Method to Synthesize Antibacterial Nanoparticles July 2nd, 2015

Leti Announces Launch of First European Nanomedicine Characterisation Laboratory: Project Combines Expertise of 9 Partners in 8 Countries to Foster Nanomedicine Innovation and Facilitate Regulatory Approval July 1st, 2015

Announcements

A 'movie' of ultrafast rotating molecules at a hundred billion per second: A quantum wave-like nature was successfully observed in rotating nitrogen molecules July 4th, 2015

New Biosensor Produced in Iran to Detect Effective Drugs in Cancer Treatment July 4th, 2015

Clues to inner atomic life from subtle light-emission shifts: Hyperfine structure of light absorption by short-lived cadmium atom isotopes reveals characteristics of the nucleus that matter for high precision detection methods July 3rd, 2015

Pioneering Southampton scientist awarded prestigious physics medal July 3rd, 2015

Tools

A 'movie' of ultrafast rotating molecules at a hundred billion per second: A quantum wave-like nature was successfully observed in rotating nitrogen molecules July 4th, 2015

Clues to inner atomic life from subtle light-emission shifts: Hyperfine structure of light absorption by short-lived cadmium atom isotopes reveals characteristics of the nucleus that matter for high precision detection methods July 3rd, 2015

Nanometrics to Announce Second Quarter Financial Results on July 23, 2015 July 2nd, 2015

NIST ‘How-To’ Website Documents Procedures for Nano-EHS Research and Testing July 1st, 2015

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project